Outcome Objectives:
1.) Describe the neuroscience of unconscious bias.
Initial findings reported by the Arizona COVID-19 Genomics Union suggest that following Arizona’s first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The results were published in mBio, an open access journal published by the American Society for Microbiology, earlier this month.
TUCSON, Ariz. – University of Arizona Health Sciences researchers are moving closer to conducting clinical trials on what would be the first therapeutic drug for vascular cognitive impairment and dementia (VCID), the second most common form of dementia after Alzheimer’s disease.
"CPC: The Wrong Way to Wash Your Hands"
Mateen Khokhar, MD, John Bloom, MD, Mazda Shirazi, MD
"Antimicrobial Stewardship in the Era of Multidrug Resistance and COVID-19"
Justin Hayes, MD
TUCSON, Ariz. — Following a national search, Geoffrey Rubin, MD, MBA, has been named chair of the Department of Medical Imaging at the University of Arizona College of Medicine – Tucson, effective Oct. 1.
As the coronavirus pandemic took hold in the U.S. six months ago, nursing homes and long-term care facilities emerged as hotspots where COVID-19 ran rampant.
A new study out today combines evolutionary genomics from coronavirus samples with computer-simulated epidemics and detailed travel records to reconstruct the spread of coronavirus across the world in unprecedented detail.
Published in the journal Science, the results suggest an extended period of missed opportunity when intensive testing and contact tracing might have prevented SARS-CoV-2 from becoming established in North America and Europe.
